- Electrochemical Biosensor
- Thermometric Biosensor
- Fiber Optic Biosensor
- Piezoelectric Biosensor
- Others
Cell Culture Monitoring Biosensors Market size was valued at USD 362 million in 2022 and is expected to grow at a CAGR of 9.2% from 2023-2029. The report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed This market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). This report gives Key stakeholders of the cell culture monitoring biosensors market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of biosensors.The report provides granular level information about the market size, regional market share, historic market and forecast . The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies. The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market. The report tracks recent innovations, key developments and startup’s details that are actively working in the market. The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario. The report analyses the impact of a socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Rising inclination towards biopharmaceutical molecules and increased R&D in the biotech field, expected to increase demand for biosensors in cell culture monitor. The pipeline of the oncology drugs in clinical development has been raised by 45% over the past decade, 87% of the late stage molecules are included biologic monoclonal antibodies and small molecule PKI. Increased production of biotechnology products and raising awareness of cell culture monitoring biosensors are expected to gain huge traction to the market. Increased accuracy witnessed to catapult the cell culture monitoring biosensors market. Biosensors enable to monitor the cell culture growth, and bi-products, contaminants effectively. For instance, therapeutic glycoproteins produced in mammalian cell cultures. Biosensors able to monitor cellular metabolism such as utilization of nutrients and production of waste products like lactic acid, overproduction of waste products decreases the production of cell culture growth. These are the few factors expected to create demand for biosensors used in cell culture.
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
8.1.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.1.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%) 8.1.2.1. Pharma & Biotech Industry 8.1.2.2. Research Organizations 8.1.2.3. Others
8.1.3.1. US 8.1.3.2. Canada
8.2.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.2.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%) 8.2.2.1. Pharma & Biotech Industry 8.2.2.2. Research Organizations 8.2.2.3. Others
8.2.3.1. Germany 8.2.3.2. UK 8.2.3.3. France 8.2.3.4. Spain 8.2.3.5. Italy 8.2.3.6. Russia 8.2.3.7. Poland 8.2.3.8. Rest of Europe
8.3.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.3.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%) 8.3.2.1. Pharma & Biotech Industry 8.3.2.2. Research Organizations 8.3.2.3. Others
Y-o-Y Growth (%) 8.3.3.1. Japan 8.3.3.2. China 8.3.3.3. India 8.3.3.4. ASEAN 8.3.3.5. Australia & New Zealand 8.3.3.6. Rest of Asia-Pacific
8.4.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.4.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%) 8.4.2.1. Pharma & Biotech Industry 8.4.2.2. Research Organizations 8.4.2.3. Others
Y-o-Y Growth (%) 8.4.3.1. Brazil 8.4.3.2. Mexico 8.4.3.3. Argentina 8.4.3.4. Venezuela 8.4.3.5. Rest of Latin America
8.5.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%)
8.5.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) and Y-o-Y Growth (%) 8.5.2.1. Pharma & Biotech Industry 8.5.2.2. Research Organizations 8.5.2.3. Others
Y-o-Y Growth (%) 8.5.3.1. Gulf Cooperation Council (GCC) Countries 8.5.3.2. Israel 8.5.3.3. South Africa 8.5.3.4. Rest of MEA Competition Landscape